|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function显示文摘 | Schreck RE West DC | 2000 | Clin Cancer Res2000，6，12： | 1 |
| 2 | Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1 显示文摘 | Ho ES Lin DC Mendel DB | 2000 | J Am Soc Nephrol2000，11，3： | 1 |
| 3 | In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetid pharmacodynamic relationship显示文摘 | Mendel DB laird AD Xin X | 2003 | Clin Cancer Res2003，9，1： | 1 |
| 4 | Glucocorticoid receptors and actions显示文摘 | Munck A Mendel DB Smith LI | 1990 | Am Rev Respir Dis1990，141，2： | 1 |
| 5 | Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1显示文摘 | Ho ES Lin DC Mendel DB Cihlar T | 2000 | J Am Soc Nephrol2000，11，3： | 1 |
| 6 | Phenotypic and genotypic assay of influenza virus neuraminidase indicates a low incidence of viraldrug resistance during treatment with oseltamivir显示文摘 | Mendel DB Escarpe PA | 1999 | Ⅱ International Symposium on Influenza and other Respratory Virus1999，11，： | 1 |
| 7 | In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship 显示文摘 | Mendel DB Laird AD Xin X | 2003 | Clin Cancer Res2003，9，1： | 1 |
| 8 | In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship显示文摘 | Mendel DB Laird AD Xin X | 2003 | Clin Cancer Res2003，9，： | 1 |
| 9 | In-vitro and in-vivo efficacy of influenza neuraminidase inhibitors 显示文摘 | Roberts NA | 1998 | Curr Opin in Infect Disease1998，11，6： | 1 |
| 10 | In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and plateletderived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship 显示文摘 | Mendel DB Laird AD Xin X | 2003 | Clin Cancer Res2003，9，3： | 1 |
| 11 | Development of SU5416, a selective small molecule inhibits of VEGF receptor tyrosine kirase activity, as an anti-angiogenesis agent显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | AntiCancer Drug Design2000，15，1： | 1 |
| 12 | The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function显示文摘 | Mendel DB Schreck RE West DC | 2000 | Clin Cancer Res2000，6，12： | 1 |
| 13 | Development of Su5416 a selective Small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an angiogenesis agent显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | J Anticancer Drug Des2000，15，1： | 1 |
| 14 | In vivo antitu- mor activity of SU11248, a novel tyrosine kinase inhib- itor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship 显示文摘 | Mendel DB Laird AD Xin X | 2003 | Clin Cancer Res2003，9，1： | 1 |
| 15 | In vivo antitumor ac-tivity of SU11248 , a novel tyrosine kinase inhibitor targe-ting vascular endothelial growth factor and platelet - de-rived growth factor receptors : determination of a pharmaco-kinetic/ pharmacodynamic relationship 显示文摘 | Mendel DB Laird AD Xin X | 2003 | Clin CancerRes2003，9，1： | 1 |
| 16 | Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection显示文摘 | Tai CY Escarpe PA | 1998 | Antimicrob Agents Chemo-ther1998，42，： | 1 |
| 17 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent 显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | Anticancer Drug Des2000，15，1： | 1 |
| 18 | In vivo antitumor activity of SUl1248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/ pharmacodynamic relationship 显示文摘 | Mendel DB Laird AD Xin X | 2003 | Clin Cancer Res2003，9，1： | 1 |
| 19 | Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1 显示文摘 | Ho ES Lin DC Mendel DB | 2000 | J Am Soc Nephrol2000，11，： | 1 |
| 20 | The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function显示文摘 | Mendel DB Schreck RE West DC | 2000 | Clin Cancer Res2000，6，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员